EUVIMEDEUVIMED entdecken
Crossref

NIR-activatable proenzyme DSF/CuS@M for synergistic in situ chemotherapy/CDT/PTT/cuproptosis-based antitumor therapy

Lushuang Xu, Qinyue Chen, Yangwei Qian, Jin Wang, Chenxi Wang, Rui Fan, Jia-Wei Shen, Qiying Shen

Chemical Engineering Journal · 2025-04 · 510 · 161733

DOI: 10.1016/j.cej.2025.161733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2025-04. Verfasst von Lushuang Xu und 7 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hangzhou Normal University, Medical Science and Technology Project of Zhejiang Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China
  • Hangzhou Normal University
  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Xu, L., Chen, Q., Qian, Y., Wang, J., Wang, C., Fan, R., Shen, J., & Shen, Q. (2025). NIR-activatable proenzyme DSF/CuS@M for synergistic in situ chemotherapy/CDT/PTT/cuproptosis-based antitumor therapy. Chemical Engineering Journal, 510, 161733. https://doi.org/10.1016/j.cej.2025.161733

Vancouver

Xu L, Chen Q, Qian Y, Wang J, Wang C, Fan R, et al. NIR-activatable proenzyme DSF/CuS@M for synergistic in situ chemotherapy/CDT/PTT/cuproptosis-based antitumor therapy. Chemical Engineering Journal. 2025;510:161733. doi:10.1016/j.cej.2025.161733

BibTeX
@article{Xu2025,
  author = {Xu, Lushuang and Chen, Qinyue and Qian, Yangwei and Wang, Jin and Wang, Chenxi and Fan, Rui and Shen, Jia-Wei and Shen, Qiying},
  title = {NIR-activatable proenzyme DSF/CuS@M for synergistic in situ chemotherapy/CDT/PTT/cuproptosis-based antitumor therapy},
  journal = {Chemical Engineering Journal},
  year = {2025},
  volume = {510},
  pages = {161733},
  doi = {10.1016/j.cej.2025.161733}
}
Kostenlos starten →